UK approves gene therapy for sickle cell disease in world first
Medical News Today,
Share on PinterestWorld-first genetic therapy approved in the U.K. may be a game changer in sickle cell disease treatment.
Hematologic Abnormalities and Acute Lung Syndromes
Overview of attention for book
Table of Contents
-
Altmetric BadgeBook Overview
-
Altmetric BadgeChapter 1 The Lung–Blood Interface
-
Altmetric BadgeChapter 2 Leukocyte Kinetics and Migration in the Lungs
-
Altmetric BadgeChapter 3 Sickle Cell Disease and Acute Chest Syndrome: Mechanisms and Pathogenenesis
-
Altmetric BadgeChapter 4 Sickle Cell Disease and Acute Chest Syndrome: Epidemiology, Diagnosis, Management, Outcomes
-
Altmetric BadgeChapter 5 Thrombophilias and Acute Pulmonary Thromboembolic Disease
-
Altmetric BadgeChapter 6 Bleeding Disorders: Diagnosis and Treatment of Hemorrhagic Complications in the Intensive Care Unit
-
Altmetric BadgeChapter 7 Acute Pulmonary Manifestations of Hematologic Malignancies
-
Altmetric BadgeChapter 8 Acute Pulmonary Complications of Bone Marrow and Stem Cell Transplantation
-
Altmetric BadgeChapter 9 Storage Lesion: Evolving Concepts and Controversies
-
Altmetric BadgeChapter 10 Transfusion and Acute Respiratory Distress Syndrome: Pathogenesis and Potential Mechanisms
-
Altmetric BadgeChapter 11 Transfusion and Acute Respiratory Distress Syndrome: Clinical Epidemiology, Diagnosis, Management, and Outcomes
-
Altmetric BadgeChapter 12 Transfusion Associated Circulatory Overload
-
Altmetric BadgeChapter 13 Transfusion-Related Immunomodulation (TRIM): From Renal Allograft Survival to Postoperative Mortality in Cardiac Surgery